Selvedge Venture

Type

Venture Capital

Status

Active

Location

London, United Kingdom

Total investments

16

Average round size

6M

Portfolio companies

10

Rounds per year

5.33

Lead investments

1

Follow on index

0.31

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyArtificial IntelligenceHealth CareMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharmaBioinformatics

Investor highlights

Industry focus
Biotech/Life SciencesAI/Big DataAnalytics
Stage focus
SeedPre-SeedSeries A
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
16
Lead investments
1
Rounds per year
5.33
Follow on index
0.31
Investments by industry
  • Biotechnology (10)
  • Health Care (9)
  • Life Science (7)
  • Artificial Intelligence (6)
  • Medical (5)
  • Show 10 more
Investments by region
  • United Kingdom (12)
  • United States (1)
  • Singapore (1)
  • Canada (1)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
5
Avg. valuation at time of investment
931K
Group Appearance index
0.94

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Mesh Bio 12 Oct 2023 Biotechnology, Analytics, Health Care, Predictive Analytics Early Stage Venture 3M Central, Bukit Merah, Singapore
Oxford Medical Products 24 Mar 2021 Medical, Life Science Seed 1M Oxfordshire, Witney, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.